Abstract:Lactate, traditionally regarded as a metabolic waste product at the terminal of the glycolysis process, has recently been found to have multifaceted functional roles in metabolism and beyond. A metabolic reprogramming phenomenon commonly seen in tumor cells, known as the “Warburg effect,” sees high levels of aerobic glycolysis result in an excessive production of lactate. This lactate serves as a substrate that sustains not only the survival of cancer cells but also immune cells. However, it also inhibits the function of tumor-associated macrophages (TAMs), a group of innate immune cells ubiquitously present in solid tumors, thereby facilitating the immune evasion of malignant tumor cells. Characterized by their high plasticity, TAMs are generally divided into the pro-inflammatory M1 phenotype and the pro-tumour M2 phenotype. Through a process of ‘education’ by lactate, TAMs tend to adopt an immunosuppressive phenotype and collaborate with tumor cells to promote angiogenesis. Additionally, there is growing evidence linking metabolic reprogramming with epigenetic modifications, suggesting the participation of histone modification in diverse cellular events within the tumor microenvironment (TME). In this review, we delve into recent discoveries concerning lactate metabolism in tumors, with a particular focus on the impact of lactate on the function of TAMs. We aim to consolidate the molecular mechanisms underlying lactate-induced TAM polarization and angiogenesis and explore the lactate-mediated crosstalk between TAMs and tumor cells. Finally, we also touch upon the latest progress in immunometabolic therapies and drug delivery strategies targeting glycolysis and lactate production, offering new perspectives for future therapeutic approaches.

Targeting L-Lactate Metabolism to Overcome Resistance to Immune Therapy of Melanoma and Other Tumor Entities

Metabolic modulation of melanoma enhances the therapeutic potential of immune checkpoint inhibitors

Lactate in the tumor microenvironment: A rising star for targeted tumor therapy

Rationale for LDH-Targeted Cancer Immunotherapy

Lactate in the tumour microenvironment: From immune modulation to therapy

Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy

Lactate metabolic pathway regulates tumor cell metastasis and its use as a new therapeutic target

Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches

LDHA: The Obstacle to T cell responses against tumor

Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies

Targeting metabolism to enhance immunotherapy within tumor microenvironment

Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance

Lactate dehydrogenase: a marker of diminished antitumor immunity

How lactate affects immune strategies in lymphoma

Harnessing Lactate Metabolism for Radiosensitization

Lactate: the Mediator of Metabolism and Immunosuppression

Potential therapeutics using tumor-secreted lactate in nonsmall cell lung cancer

Targeting glycolysis for cancer therapy using drug delivery systems

Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models

Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors